Antroquinonol

安卓奎诺尔

Report date: 2023/03/23 10:23:54
NME

Base Information

Drug NameAntroquinonol
Drug Alias Name安卓奎諾尔Hocena
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases activators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)HyperlipidemiasDermatitis, Atopic +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanRussian Federation +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGolden Biotechnology Corporation Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBNC Korea Co LtdGolden Biotechnology Corporation Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Alzheimer DiseasePancreatic Neoplasms +[4] 
Inactive IndicationsHyperlipidemiasDermatitis, AtopicCarcinoma, Non-Small-Cell Lung +[4] 

Other Information

ATC CodeN/A
Related LinksN/A